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ABSTRACT
Hepatitis C infection is a major public health problem that can be dealt with urgent and 
timely attention. Recently, WHO Global Hepatitis Report showed that 71 million people, 
equivalent to approximately 1% of the world population, are infected with hepatitis C. 
The disease incidence, mortality rate and risk factors vary across geographical regions. 
The virus is transmitted primarily through drug injection and exposure to infected blood 
products in healthcare and community settings. The common causes of death related to 
virus infections are decompensated liver cirrhosis and hepatocellular carcinoma. Hepatitis 
C infection is mainly prevented by identifying and controlling any possible risk factors for 
virus transmission because treatment is costly and limited in availability. In this review, 
articles discussing the natural history, epidemiology and risk factors for hepatitis C infection 
are reviewed. 
Keywords: Epidemiology, hepatitis C virus, infection, 
mortality, risk factors, transmission
INTRODUCTION
Hepatitis C is a blood-borne disease that 
results from infection with the hepatitis C 
virus (HCV). World Health Organization 
(WHO) estimated that 71 million persons 
would be living with chronic HCV infections 
by 2015 (WHO, 2017a). According to 
the Global Hepatitis Report, the global 
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incidence rate is highest in the WHO Eastern Mediterranean (23.7 per 100,000 population) 
and European regions (61.8 per 100,000 population) (WHO, 2017a). The global mortality 
rate from viral hepatitis is 18.3 deaths per 100,000 population. The Western Pacific region 
has the lowest incidence rate but also showed the highest mortality rate (24.1 deaths per 
100,000 population), followed by the Southeast Asian region (21.2 deaths per 100,000 
population) (WHO, 2017a). HCV chronically affects the liver, and the global burden 
attributed to HCV-related liver disease is substantial and expected to increase in the next 
few years (Razavi et al. 2014). 
A vaccine for preventing hepatitis C infection is still unavailable (WHO, 2017b). 
Thus, the infection is prevented mainly by identifying and controlling any possible risk 
factors that promote virus transmission. Prevention can be accomplished through the 
implementation of safety precaution by healthcare workers, introduction of reuse preventive 
devices, reduction of unnecessary healthcare injection (WHO, 2016), implementation of 
harm reduction interventions for people who inject drugs (PWIDs) (Csete et al., 2016) and 
provision of access to treatment and early screening for high-risk groups (WHO, 2017a). 
Thus, the pathogenesis, disease distribution and infection risk factors for HCV must be 
understood for the planning of appropriate preventive strategies. 
In this review article, the authors conducted a literature search for articles related 
to the natural history, epidemiology and risk factors of hepatitis C infection through 
several online databases (e.g. Cumulative Index to Nursing and Allied Health Literature, 
Cochrane database, PubMed, Medical Literature Analysis and Retrieval System Online, and 
Science Direct). The search terms included ‘hepatitis C’, ‘pathogenesis’, ‘epidemiology’, 
‘incidence’, ‘prevalence’, ‘mortality’ and ‘risk factors’. Only articles and abstracts published 
in English were included in this review. For risk factor section, articles with systematic 
reviews, cohort or case-control study designs were selected as such high-quality study 
designs provide stronger evidence that an exposure is associated with hepatitis C infection. 
HCV NATURAL HISTORY
Route of Transmission
Humans are the only known natural hosts for HCV (Pawlotsky, 2004). HCV is blood-borne 
and thus transmitted by contaminated blood mainly via clinical procedures (surgery, blood 
transfusion and needle stick injuries) and intravenous drug use. As improved testing and 
screening methods for blood donors become increasingly available, blood transfusion is 
becoming safer than before, and the principal cohorts of newly infected patients are now 
PWIDs.
Hepatitis C Infection: Natural History, Epidemiology and Risk Factors
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Pathogenesis of HCV
After entering a susceptible host, HCV invades, infects and replicates within the 
bloodstream, repeating the process in various tissues, as it proceeds to the liver, a principal 
site for virus replication (Chen & Morgan, 2006). HCV infection causes acute infection in 
which most patients (70%–80%) do not develop symptoms (Figure 1). In the remaining 
20%–30% of patients, acute hepatitis exhibits mild symptoms and is thus infrequently 
diagnosed (Chen & Morgan, 2006; Omata et al., 2016). Symptoms occur 6–7 weeks after 
exposure on average, but it can range from 2 weeks to 6 months (Westbrook & Dusheiko, 
2014). 
The initial features of the acute illness are non-specific flu-like symptoms. Additional 
specific symptoms of viral hepatitis, such as jaundice, dark urine, anorexia and abdominal 
discomfort, can be encountered in only a few individuals with acute hepatitis (Westbrook 
& Dusheiko, 2014). Acute hepatitis is self-resolved in 20%–50% of incidences but chronic 
in most cases (Pawlotsky, 2004). A patient may remain undiagnosed until they manifest 
complications of end-stage liver disease.
Chronic HCV infection is marked by the persistence of HCV RNA in the blood for at 
least 6 months after the onset of acute infection (Gupta et al., 2014). The progression to 
chronic state is influenced by several factors, such as age, gender, ethnicity, co-infection with 
the human immunodeficiency virus (HIV) or Hepatitis B virus (HBV), alcohol consumption 
and other co-morbid conditions, such as cancer, obesity and immunosuppression (Gupta et 
al., 2014). Twenty to 30 years after initial HCV infection, persistent hepatic inflammation 
leads to the development of cirrhosis in approximately 10%–20% of patients (Omata et 
al., 2016; Westbrook & Dusheiko, 2014). 
Once cirrhosis is diagnosed, 1%–5% annual risk of developing hepatocellular 
carcinoma (HCC) and 3%–6% annual risk of hepatic decompensation and eventual death 
are observed (Modi & Liang, 2008; Omata et al., 2016; Westbrook & Dusheiko, 2014). 
Patients with decompensated cirrhosis have 15%–20% risk of dying the following year, and 
liver transplants are the only potential treatment option for such patients. HCV-associated 
liver disease is the leading reason for liver transplant in the US (Wong et al., 2015). 
Figure 1 shows the progression of HCV infection from initial viral exposure until 
death. The risk percentage for each disease stage is given in parentheses. (Source: Chen 
& Morgan, 2006; Gupta et al., 2014; Modi & Liang, 2008; Omata et al., 2016; Pawlotsky, 
2004; Westbrook & Dusheiko, 2014).
Seventy to 74% of HCV patients experience extrahepatic conditions (Cacoub et al., 
2000). Such diseases as sicca syndrome, lichen planus, type 2 diabetes and non-Hodgkin’s 
lymphoma are linked to chronic HCV infection (Westbrook & Dusheiko, 2014). The risk of 
developing non-Hodgkin’s B cell lymphoma is also increased with HCV infection. Patients 
with HCV infections are prone to developing insulin resistance, hence type 2 diabetes which 
in turn increases the risk of vascular diseases (Antonelli et al., 2014). 
Mohd Azri Mohd Suan, Salmiah Md Said, Ahmad Zaid Fattah Azman and Muhammad Radzi Abu Hassan
1344 Pertanika J. Sci. & Technol. 27 (3): 1341 - 1359 (2019)
Causes of death among patients with HCV vary with age. The primary cause of death of 
patients aged 20–39 years is unnatural factors (death from external causes or due to mental 
and behavioural disorders related to psychoactive substance use) (Omland et al., 2011). 
Deaths of patients aged 40–59 years are equally caused by liver-related, non-liver-related 
and unnatural causes. The most common causes of death of the elderly are non-liver-related. 
In a previous study, the cause of death of HCV-infected patients was explored using data 
from the death registry of four countries (Australia, Sweden, Scotland and Denmark) 
(Grebely & Dore, 2011). The results revealed that among HCV patients, the proportion 
of liver disease-related deaths (including decompensated cirrhosis and HCC) varied from 
10% to 24%, and that of drug-related deaths (such as drug overdose and suicide) was 
from 18% to 27%. The proportion of HIV-related deaths ranged between 0.4% and 7.9%. 
HCV EPIDEMIOLOGY
A comprehensive literature review performed by Petruzziello et al. (2016) using data 
published up to 2015 revealed that total global HCV prevalence (adults) was estimated 
at 2.5%, which was equalled to 177.5 million. The global time trends of HCV prevalence 
were described by Hanafiah et al. (2013) in their systematic review article on the global 
epidemiology of HCV infection. The number of persons found positive for anti-HCV 
antibody increased from 122 million in 1990 to more than 184 million in 2005. Nineteen 
Figure 1. Natural Progression of Hepatitis C Infection
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Global Burden of Disease regions (excluding west sub-Saharan Africa and the Middle 
East) showed an increase in HCV prevalence between 1990 and 2005. In 2005, the HCV 
prevalence in west sub-Saharan Africa and the Middle East decreased from 4.0% to 2.8% 
and from 4.2% to 3.7%, respectively. 
The same study also mentioned that the prevalence pattern across age groups was 
similar in all regions. Remarkably low prevalence was seen in the age group below 20 years 
old. This prevalence increased with age and peaked at 55–64 years (Hanafiah et al., 2013). 
For gender distribution, a systematic review found that men had higher prevalence than 
women (Bruggmann et al., 2014). However, women of age over 69 had higher prevalence 
due to unscreened blood transfusion after childbirth in France and Germany. In Turkey, as 
more women being hospitalised, nosocomial infection was thought to be the main reason 
for women becoming more infected than men (Bruggmann et al., 2014).
HCV prevalence also varies across WHO regions. The WHO Eastern Mediterranean 
and European regions have the most number of affected patients, with prevalence of 2.3% 
and 1.5%, respectively (WHO, 2017b). The prevalence of HCV infection in other WHO 
regions varies from 0.5% to 1.0%. The prevalence variation can be related to differences in 
the proportion of high-risk behaviour across populations. For instance, HCV transmission 
in most developed countries is primarily through drug injection, whereas exposure to 
infected blood products in healthcare and community settings is common among patients 
from developing countries (Averhoff et al., 2012). 
The global number of deaths due to viral hepatitis is increasing. The estimated number 
of deaths gradually increased from 1.2 million in 2000 to 1.4 million in 2010; these 
deaths were mostly due to hepatitis-related liver cancer and cirrhosis (WHO, 2016). Of 
these deaths, 48% were due to HCV infection. In another mortality report by CDC, more 
Americans now die due to HCV infection than those by all other infectious diseases (Ly et 
al., 2016). The number of deaths in America due to HCV infection increased from 11,051 
in 2003 to 19,368 in 2013. 
RISK FACTORS OF HCV INFECTION
Through the literature search, various risk factors for HCV infection were found. These 
factors were grouped into four main categories to ease understanding. The categories 
were occupational profile, medical history, high-risk behaviour and traditional practices. 
Summary of reviewed literature for risk factors of HCV infection are presented in Table 1. 
Occupational profile 
Healthcare Workers. Westermann et al. (2015) conducted a systematic review comparing 
the prevalence of HCV infection among healthcare workers and the general population. 
Their meta-analysis indicated that the probability of HCV infection among healthcare 
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workers was 1.6 times higher than that for the control population. Further analysis by 
occupational group stratification revealed that medical, dental and laboratory staff had 2.7, 
3.5 and 2.2 times higher risk of HCV infection, respectively, in comparison with the control 
group. Nursing staff had an insignificant risk of contracting HCV infection despite that they 
handle patients more frequently than do other healthcare groups (Westermann et al., 2015).
Marine-related Work. Individuals with marine-related work, mainly fishermen, have 
an increased risk of infection (HIV, HCV, HBV) because the nature of their work, which 
requires them to be away from home for extended periods (West et al., 2014), makes them 
likely to seek casual partners and engage in drug addiction, which are risk behaviours that 
promote the above-mentioned infectious diseases. A matched hospital-based case-control 
study was conducted in the Republic of Korea to examine the risk factors associated with 
HCV infection (Sohn et al., 2016). Their study analysis was based on information obtained 
from a sample with 234 participants in each case (patient with positive HCV infection) and 
patient-control (patient with negative hepatitis C antibody) groups. The research found that 
11.1% of patients with HCV infection had marine-related occupations; these individuals 
were fishery workers, sailors and dockworkers. Multiple logistic regression analysis showed 
that contact dockworkers had nearly twice as much risk of HCV infection compared with 
the patient-control group. 
Medical History
Blood Transfusion. Various case-control studies have investigated and revealed a strong 
association between blood transfusion and HCV infection. Rosa et al. (2014) conducted 
a matched population-based case-control study at a medium-sized town in Catanduva 
state, Brazil involving 190 participants for each case and control group. The study found 
that participants with HCV infection were 7 times more likely to have blood transfusion 
in the past than in the control group (Rosa et al., 2014). Another matched hospital-based 
case-control study was performed at five blood donation centres in China (Huang et al., 
2015). The study findings indicated that donors with previous blood transfusion had nearly 
10 times higher risk of HCV infection than those without any previous blood transfusion. 
However, the findings cannot be generalised to the general population because the study 
sample consisted merely of blood donors. In Egypt, Kandeel et al. (2012) conducted a 
hospital-based case-control study among 86 patients and 287 controls. Study analyses 
revealed that the variable ‘receiving blood transfusion’ was significant in univariate analysis 
but not in the multiple regression analysis.
Needle Stick Injury. Needle stick injuries containing blood from infected patients and 
mucosal exposure to contaminated blood or body fluids are common modes of infection 
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among healthcare workers (Pozzetto et al., 2014). Gorar et al. (2014) reported that among 
their study population, those who had needle stick injuries were 6 times more likely to 
contract hepatitis C than was the control group. Additionally, attempts to recap needles 
after use was also a risk factor associated with hepatitis C infection, according to multiple 
logistic regression analysis. Rosa et al. (2014) reported that participants with history of 
accidents with syringes and/or needles had 11 times higher probability of contracting HCV. 
Haemodialysis. Sohn et al. (2016) found that blood dialysis was not a significant risk 
factor for HCV infection. This result was probably skewed by the involvement of only a 
small number of patients with history of blood dialysis in the studied population. Sun et 
al. (2009) conducted a systematic review of HCV infection and related risk factors among 
haemodialysis patients in China. The review found that haemodialysis patients who had 
long treatment durations and received blood transfusions during haemodialysis were 
associated with an increased risk of HCV infection. Additionally, HCV infection rates 
was significantly higher among patients who had haemodialysis for 1 year or more than 
individuals who underwent haemodialysis for less than a year (Sun et al., 2009). 
Surgical Procedures. Incidents of surgery-related HCV transmission resulted from 
breaches in injection safety and infection prevention practices have been documented 
in many previous studies (Kandeel et al., 2012; Karmochkine et al., 2006; Sohn et al., 
2016). Karmochkine et al. (2006) conducted a population-based case-control study in 
France, in which 460 HCV-infected patients and 757 controls participated. Their multiple 
regression analysis identified digestive endoscopy and abortion as independent risk factors 
for HCV infection. Other significant medical procedures associated with HCV infection 
were varicose vein sclerotherapy and ulcer wound care. In another hospital-based case-
control study (Kandeel et al., 2012), patients with history of invasive procedures (including 
minor surgeries) had 4.7 times higher risk of HCV infection than those who had not 
undergone such procedures. By contrast, Sohn et al. (2016) concluded that gastroscopy 
and colonoscopy were not risk factors for HCV infection. 
HIV Infection. HIV-infected individuals have an increased risk of HCV infection because 
these infections share several common routes of transmission, namely, parenteral, sexual 
and vertical exposures (Rotman & Liang, 2009). However, the prevalence rates of HIV–
HCV co-infection greatly differ among high-risk groups. The highest co-infection rates 
were found among PWIDs and were between 65% and 87% (Bollepalli et al., 2007; 
Cacoub et al., 2015). A retrospective cohort study in Korea identified that HIV-infected 
injectable drug users had 16 times higher risk of HCV infection than HIV-infected non-
users of injectable drugs (Lee et al., 2016). Sexual risk factors were found not associated 
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with co-infection (Bollepalli et al., 2007). Nevertheless, the prevalence rate of HCV–HIV 
co-infection among men who have sex with men (MSM) increased from 4% to 6% in a 
10-year period (Cacoub et al., 2015).
Vertical Transmission. HCV can be transmitted from infected mothers to their children at 
all stages of pregnancy, namely, antenatal, intrapartum and postnatal (Arshad et al., 2011; 
Mok et al., 2005). A meta-analysis by Benova et al. (2014) revealed that more than 1 in 
20 babies born to HCV-infected mothers were infected through vertical transmission. This 
study also identified that maternal HIV co-infection introduced children to 2.6 times higher 
risk for HCV infection through vertical transmission when compared to HIV-negative 
mothers (Benova et al., 2014). 
High-risk Behaviour
Persons Who Inject Drugs. Several case-control studies have shown an association 
between PWIDs and risk of HCV infection. Jimenez et al. (2009) designed a matched 
hospital-based case-control study in Egypt, where 94 HCV-positive patients and 188 
controls were enrolled. Multiple logistic regression analysis indicated that injection drug 
use was independently linked to HCV infection. In another study in Egypt by Kandeel et 
al. (2012), PWIDs carried 12 times higher risk of HCV infection than the control group. 
Having sexual contact with PWID also carried 3.5 higher risk for HCV infection (Brandao 
and Fuchs, 2002). Similarly, Sohn et al. (2016) found that the risk of contracting HCV 
by Koreans increased by nearly 4 times with the involvement of intravenous drug abuse. 
However, this association became insignificant after other variables were adjusted in 
multiple regression analysis. Rosa et al. (2014) investigated the association between PWIDs 
and risk of HCV infection among Brazilian population. Their study analysis found that 
33.2% of HCV carriers had previous or current injectable drug use. However, none of the 
participants in the control group was reported of injectable drug use. Consequently, the 
authors could not conduct a comparative analysis.  
Intranasal Drug Use. Intranasal drug use is also associated with an increased risk of HCV 
infection. Sniffing illicit drugs was mentioned by Jimenez et al. (2009) to be related to 
contracting HCV. In a study in Brazil by Rosa et al. (2014), the risk of HCV infection was 
found to be 7 times greater among participants who used non-injectable illicit drugs than 
among those who did not use non-injectable illicit drugs. Karmochkine et al. (2006) also 
suggested that HCV was significantly associated with intranasal cocaine use.  
Tattoos. Jafari et al. (2010) evaluated HCV infection risks related to tattooing by 
systematically reviewing 124 studies, of which 83 were included in a meta-analysis. The 
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pooled odds ratio (OR) of the association between tattooing and HCV infection from 
all studies was 2.74. Kin et al. (2013) conducted a matched hospital-based case-control 
study among Asian Americans residing in northern California. A total of 384 patients were 
recruited into each case and control group. For Asian Americans ethnic cases compared 
with controls, body tattoo was a common risk factor, but it was present in only a small 
proportion of cases (4.4% vs. 0.5%, p=0.001). Nonetheless, in multiple logistic regression, 
HCV infection was 12 times higher among those with body tattoos than those without such 
tattoos (Kin et al., 2013). Two other studies also indicated a strong relationship between 
tattoos and HCV infection. Among the Korean population, persons with tattoos were 
twice as likely to contract HCV as those in the patients-control (Sohn et al., 2016). Rosa 
et al. (2014) also confirmed the link between tattoos and HCV infection among Brazilian 
population. 
Imprisonment. The association between imprisonment and risk of HCV infection has 
been proven in several studies. Kandeel et al. (2012) reported that 7.0% of HCV-positive 
participants were imprisoned within six months before the study, whereas merely 0.3% 
of the controls had such history. Imprisonment is also a risk factor for HCV infection in 
the Republic of Korea. Sohn et al. (2016) revealed that imprisonment could double the 
risk of contracting HCV. However, no significant association was established via multiple 
logistic regression analysis in both studies (Kandeel et al., 2012; Sohn et al., 2016). By 
contrast, a population-based case-control study conducted in Brazil stated that history of 
imprisonment was an independent risk factor for HCV infection (Brandão & Fuchs, 2002). 
Cosmetic Treatment (Including Pedicures and Manicures). Reuse of blood-contaminated 
instruments that are not adequately cleaned and sterilised is a possible mode of HCV 
transmission during cosmetic procedures. However, three studies that explored the role of 
cosmetic treatment as a risk factor for HCV infection gave inconsistent findings. Firstly, in 
multivariate analysis by Karmochkine et al. (2006), having beauty treatments or pedicures/
manicures were independently associated with an increase in HCV risk. However, a study 
by Sohn et al. (2016), which considered the Korean population, showed that manicures 
were not a significant risk factor after other variables were adjusted. Similarly, a third 
study by Jimenez et al. (2009) in Egypt revealed that manicures were not associated with 
an increased risk of HCV infection. 
Contact Sports. In contact sports, such as rugby and boxing, individuals can come into 
contact with blood through percutaneous injuries and thus have an increased possibility 
of HCV transmission. Only one study has explored the potential of engagement in contact 
sports as a risk factor for HCV infection. A study by Karmochkine et al. (2006) showed 
that participation in contact sports could double the risk of HCV infection. 
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Sexual Contact with HCV Carriers Among Monogamous Couples. The risk of HCV 
infection via sexual activity is remarkably low in monogamous heterosexual relationships. 
El-Ghitany et al. (2015) in their systematic review and meta-analysis found that having 
HCV infected partner carried 3 times greater risk for HCV infection. Study by Brandao and 
Fuchs (2002) also found similar result. However, study by Rosa et al. (2014) reported that 
sexual contact with HCV carriers was not an independent risk factor for HCV infection.  
Men Who Have Sex with Men. There is a rise in the incidence of sexually acquired HCV 
among the MSM community (Chan et al., 2016). Asian countries have a lower incidence 
rate than do European countries. In South Korea, the incidence rate of HCV infection among 
HIV-infected MSM patients who deny use of injectable drugs is 1.40/1,000 person-years 
(Lee et al., 2016). Injectable drug use was the only independent risk factor for the prevalence 
of HCV infection in this study. In the cross-sectional study by Urbanus et al. (2014) on 777 
HIV-positive MSM who visited the STI clinic in Amsterdam, the seroprevalence of HCV 
escalated from 5.6% in 1995 to 10.3% in 2010, peaking in 2008 (20.9%). Additionally, 
HCV infection in this population was associated with chlamydia infection, injectable drug 
use, unprotected anal intercourse and old age (Urbanus et al., 2014). Nevertheless, most 
studies investigating MSM as a risk factor for HCV infection were conducted in the MSM 
population itself and did not compare such individuals with the general population. 
Sex with Female Sex Workers/Prostitutes. Female sex workers/prostitutes can be a 
source of HCV infection, but the prevalence of infection contracted from them is relatively 
small, ranging from 0.8% to 6.6% (Laurent et al., 2001; Wang et al., 2014). Russell et al. 
(2009) conducted a hospital-based case-control study and found that sexual intercourse 
with high-risk persons, frequent casual sexual intercourse and exposure to blood during 
sexual activity were not significant predictors for HCV infection.
Traditional Practices
Acupuncture. Many articles cited acupuncture as a risk factor for HCV infection owing 
to the presence of HCV genetic material on acupuncture needles used for patients known 
to be carriers of the virus (Lemos et al., 2014). In France, participants with history 
of acupuncture have 1.5 times higher risk of HCV infection than individuals without 
such history (Karmochkine et al., 2006). A study by Brandao and Fuchs (2002) found 
contradictory results. The researchers concluded that acupuncture was not a significant 
high-risk practice leading to HCV infection. 
Cupping Therapy. Cupping therapy, a traditional method of ventouse blood-letting 
procedure, is popular in Egypt, Arabic countries and the Asian region (Mehta & Dhapte, 
Hepatitis C Infection: Natural History, Epidemiology and Risk Factors
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2015). Cupping is commonly performed as an alternative for pain treatment, inflammation 
reduction, relaxation and well-being improvement (Mehta & Dhapte, 2015). However, the 
hygiene and sterilisation status of equipment used during the therapy is uncertain because 
this procedure is performed mostly by non-medical personnel. A meta-analysis concluded 
that cupping therapy presented a heightened risk of HCV infection, with a pooled OR of 
1.40 (El-Ghitany et al. 2015).
Body Piercing. Aside from the common ear and nose piercings, lip, tongue, nipple 
and genital piercings are becoming popular throughout the world and across all ages 
(Laumann & Derick, 2006). Yang et al. (2015) conducted a systematic review to establish 
the association between body piercing and transmission of HCV. The authors performed 
a data analysis of 30 studies (16 cross sectional studies and 14 case-control studies). The 
meta-analysis indicated a considerable risk of HCV infection, with a pooled OR of 1.83, 
among individuals with body piercings. 
Male Circumcision by Traditional Practitioners. WHO estimated that one-third of males 
aged 15 years or older, mostly Muslims, would be circumcised by 2007 (WHO & Joint 
United Nations Programme on HIV/AIDS, 2007). Circumcision is highly prevalent in 
Islamic countries but is also commonly practised in parts of African countries mainly as a 
preventive measure to counter HIV epidemic (Wise, 2006). Findings from a meta-analysis 
by El-Ghitany et al. (2015) indicated that male circumcision was not a significant risk factor 
for HCV infection. Another cross-sectional study evaluating the association between male 
circumcision and HCV infection was conducted in southern Cameroon (Pépin et al., 2010). 
This study found that male circumcision by traditional practitioners was not a significant 
risk after other variables were adjusted in multivariate modelling.  
Home Birth by Traditional Midwives. Home births facilitated by traditional midwives 
was commonly practised for several centuries before the advent of modern medicine. 
Similar to the cleanliness of equipment used in circumcision, that in this mode of birth 
is questionable; moreover, this practice can transmit HCV because it involves blood and 
body fluids. Metwally et al. (2014) conducted a hospital-based case-control study among 
the Egyptian population. Results from this study analysis showed that among Egyptian 
women, delivery at home with traditional midwives was associated with increased HCV 
infection risk of 3 and 4 times in comparison with delivery by doctors at the hospital, 
respectively. However, no multiple logistic regression analysis was conducted in this study. 
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Table 1
Summary of reviewed literature for risk factors of HCV infection
Authors, year 
of publication Study design
Sample size and population 
setting Significant risk factors
Benova et al. 
(2014)
Systematic review 
and meta-analysis
109 studies of HCV vertical 
transmission risk included in 
systematic review and meta-
analysis 
Maternal HIV co-infection (aOR 
2.6).
Brandão and 
Fuchs (2002)
Hospital-based, 
case-control study
178 HIV posit ive blood 
donors and 356 controls 
recruited from eight blood 
centres in southern, Brazil
Been imprisoned (aOR 5.2), 
blood transfusion (aOR 9.9), 
tattoo (aOR 4.4), PWID (aOR 
105.2), sexual intercourse with 
HCV positive partner (aOR 3.7), 
sexual intercourse with partner 
of PWID (aOR 3.5).
El-Ghitany 
et al. (2015)
Systematic review 
and meta-analysis
357 studies on HCV risk 
factors included in systematic 
review and meta-analysis. 
PWID (pooled OR 9.0), MSM 
(pooled OR 2.4) ,  HIV co-
infection (pooled OR 4.6), 
tattoo (pooled OR 2.3), been 
imprisoned (pooled OR 2.3), 
blood transfusion (pooled OR 
2.5), hospitalization (OR 2.5), 
having HCV positive partner 
(pooled OR 3.4), haemodialysis 
(pooled  OR 2.9) ,  medica l 
procedures (pooled OR 1.6), 
acupuncture (pooled OR 1.8), 
cupp ing  ( aOR 1 .4 ) ,  body 
piercing (pooled OR 1.2). 
Gorar et al. 
(2014) 
Population-based, 
case-control study
81 healthcare workers with 
HCV positive and 83 controls 
from rural district of Pakistan
Needle stick injury (aOR 6.0), 
recap needle after use (aOR 5.7), 
treated at A&E hospital (aOR 
5.5), female gender (aOR 3.4). 
Huang et al. 
(2015)
Hospital-based, 
matched case-
control study
174 HCV positive blood 
donors and 174 controls from 
five blood centres in China
Received blood transfusion 
(OR 9.9), tattoo (OR 2.8), body 
piercing (OR 1.5), intravenous 
medicine injection (OR 1.8).*
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Authors, year 
of publication
Study design Sample size and population 
setting
Significant risk factors
Jafari et al. 
(2010)
Systematic review 
and meta-analysis
124 studies include in 
systematic review and 83 
studies in meta-analysis. All 
studies related to tattooing 
as risk factor for hepatitis C
Tattoo (pooled OR 2.7).
Kandeel et al. 
(2012)
Hospital-based, 
case-control study
86 patients with HCV 
infection and 287 controls 
from two hospitals in Cairo 
and Alexandria, Egypt
PWID (aOR 12.1), invasive 
medical procedures (aOR 4.7), 
been admitted to hospital (aOR 
7.8).
Karmochkine 
et al. (2006)
Population-based, 
case-control study
450 HCV seropositive 
patients and 757 
seronegative controls in 
Paris
Digestive endoscopy (aOR 
1.9), abortion (aOR 1.7), 
sclerotherapy (aOR 1.6), 
wound care treatment (aOR 
10.1), acupuncture (aOR 1.5), 
intranasal coccaine use (aOR 
4.5), contact sports (aOR 2.3), 
beauty treatments (aOR 2.0), 
pedicure/manicure (aOR 1.7).
Kin et al. 
(2013)
Hospital-based, 
matched case-
control study
384 patients of Asian 
Americans ethnic with HCV 
positive and 384 controls 
recruited from two clinics in 
Northern California 
Acupunture or exposure to 
dirty needles (OR 12.9), 
body tattoo (OR 12.0), blood 
transfusion (OR 5.7).*
Lee et al. 
(2016)
Retrospective 
cohort study
45 HCV positive patients 
and 745 HCV negative 
patients from a tertiary care 
hospital in Korea
PWID (aOR 16.2).
Metwally et al. 
(2014)
Hospital-based, 
case-control study
540 HCV patient and 102 
controls at six health centres 
in Egypt
Medical procedures 
[laparoscopy (OR 2.3), cannula 
(OR 2.3), wound sutures 
(OR 1.9), endoscopy (OR 
5.0)], delivery by traditional 
midwives (OR 3.9), home birth 
(OR 2.9).*
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Authors, year 
of publication
Study design Sample size and population 
setting
Significant risk factors
Jimenez et al. 
(2009)
Hospital-based, 
m a t c h e d  c a s e -
control study
94 HCV patients and 188 
controls in two hospitals at 
Greater Cairo, Egypt
PWID (aOR 7.9), illicit drug 
sniffing (aOR 4.4), medical 
stiches (aOR 4.2), medical 
intravenous injection (aOR 5.0). 
Rosa et al. 
(2014)
Population-based, 
case-control study
190 chronic HCV carriers 
and 190 controls recruited 
from Sao Paulo, Brazil
Blood transfusion (aOR 7.33), 
needle stick injury (aOR 11.0), 
tattoo (aOR 6.9), use of non-
injectable drugs (aOR 7.6).
Russell et al. 
(2009)
Hospital-based, 
case-control study
170 HCV positive patients 
and 345 controls of STD 
clinic, western New York 
state
PWID (aOR 20.2), intranasal 
drug use (aOR 1.8).
Sohn et al. 
(2016)
Hospital-based, 
m a t c h e d  c a s e -
control study
234 HCV patients and 234 
patient controls from three 
hospitals in Korea
Dockworker (aOR 1.9), tattoo 
(aOR 2.2).
Sun et al. 
(2009)
Systematic review 
and meta-analysis
43 studies on HCV infection 
a m o n g  h a e m o d i a l y s i s 
patients in China included in 
systematic review and meta-
analysis.
Haemodialysis  with blood 
transfusion (pooled OR 5.7).
Westermann 
et al. (2015)
Systematic review 
and meta-analysis
57  s tud ies  inc luded  in 
systematic review and 44 
studies in meta-analysis. 
All studies related to HCV 
infection among healthcare 
workers
Medical personnel (pooled OR 
2.7), dental staff (pooled OR 
3.5), medical laboratory staff 
(pooled OR 2.2).
Yang et al. 
(2015) 
Systematic review 
and meta-analysis
30 studies on body piercing 
as  r i sk  fac tor  for  HCV 
infection were included in 
systematic review and meta-
analysis 
Body piercing (pooled OR 1.8).
* No multivariable regression analysis, only univariable analysis available.
Note: A&E, accident and emergency; aOR, adjusted odd ratio; OR, odd ratio; HCV, hepatitis C virus; 
HIV, human immuno-deficiency virus; MSM, men who have sex with men; PWID, person who inject 
drugs; STD, sexually transmitted disease.
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CONCLUSION
The high prevalence, incidence and mortality rate of HCV infection at the global level 
indicates that the challenge in preventing HCV transmission is far from over. The 
difficulty in detecting this virus infection at early stages worsens the situation. Thus, the 
best preventive strategy is through awareness of the risk factors for virus transmission. 
Individuals belonging to high-risk groups (healthcare workers, PWIDs and prisoners) 
should take extra precaution to avoid infection. Nevertheless, more study is needed to 
establish links between HCV infection and several high-risk activities that are commonly 
practised in the community, such as contact sports, cosmetic treatments and home births. 
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